Tizanidine
Product Images NDC 60760-719

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 60760-719). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tiz (Tizanidine 60760 719 04)

This is a description of Tizanidine tablets, USP with 2mg strength. It includes information on the drug code (DX), the manufacturer, and the National Drug Code. The package was manufactured by a company called Sty I CossoTeoT. The drug is intended to be used as directed and should be stored at controlled room temperature. The description also includes a phone number for information and the address of the packaging company.*

FDA Label Image

Tizanidine-1 (Tizanidine 1)

FDA Label Image

Tizanidine-2 (Tizanidine 2)

FDA Label Image

Tizanidine-3 (Tizanidine 3)

FDA Label Image

Tizanidine-4 (Tizanidine 4)

The text describes an improvement in Ashworth score with a mean dose of 26.8 mg. It also mentions different study weeks, including the end of titration, end of maintenance, and endpoint with last observation carried forward.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.